Medical Condition News

RSS

Study demonstrates memory-enhancing effects of low-level light therapy

It's called the "Silver Tsunami" - the swelling number of baby boomers surpassing age 65. As medical advancements extend their lives, they're expected to live well into their 80s and 90s - outlasting any generation in American history.

22 Nov 2012

FDA accepts MAP Pharmaceuticals’ resubmission of NDA for LEVADEX

MAP Pharmaceuticals, Inc. today announced that its New Drug Application (NDA) resubmission for LEVADEX orally inhaled migraine drug for the potential acute treatment of migraine in adults has been accepted for filing by the U.S. Food and Drug Administration (FDA).

22 Nov 2012

UPR pathway helps tumor cells escape apoptosis during development of lymphoma

A pathway called the "Unfolded Protein Response," or UPR, a cell's way of responding to unfolded and misfolded proteins, helps tumor cells escape programmed cell death during the development of lymphoma.

21 Nov 2012

No differences between computer-navigated and traditional TKA related to knee function, pain

For many years, the use of computer-assisted navigation has been touted as improving the positioning, sizing and alignment of replacement knee joints, resulting in greater durability of joints and overall improvement in patient movement. However, new research published in the Journal of Bone and Joint Surgery (JBJS) found no difference in knee function, alignment or durability/survivorship between joints positioned and completed with the help of computer navigation, and those replaced with conventional total knee arthroplasty (TKA) procedures.

21 Nov 2012

Rexahn's quinoxalinyl-piperazine compounds receive U.S. patent

Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company dedicated to developing and commercializing first-in-class oncology therapeutics, today announced that it has been issued a United States patent (No. 8,314,100), titled "1-[6,7-substituted alkoxyquinoxalinyl) aminocarbonyl]-4-(hetero) arylpiperazine derivatives."

21 Nov 2012

Regorafenib able to control resistant gastrointestinal stromal tumor

A new targeted drug demonstrated its ability to control metastatic gastrointestinal stromal tumor, an uncommon and life-threatening form of sarcoma, after the disease had become resistant to all existing therapies, report investigators at Dana-Farber Cancer Institute who led the worldwide clinical trial.

21 Nov 2012

Australian TGA approves Genzyme’s AUBAGIO to treat relapsing forms of multiple sclerosis

Genzyme, a Sanofi company, announced today that the Australian Therapeutic Goods Administration (TGA) has approved AUBAGIO (teriflunomide) 14 mg as a new once-daily, oral treatment indicated for patients with relapsing forms of multiple sclerosis (MS).

21 Nov 2012

Viewpoints: Protecting us from counterfeit medicines; Governors making excuses on insurance exchanges?; Simpson-Bowles and the health law

HHS has made it clear that after federally operated exchanges are up and running, states may eventually take over operations. This seems like wasted effort. States have the information they need to move on insurance exchanges. Governors who care about fiscal responsibility, strong state government and the basic welfare of their residents would do well to get with the program.

21 Nov 2012

FOCUS Clinics Director performs KAMRA Vision surgery on two distinguished ophthalmologists

Dr. David Allamby, Director of FOCUS Clinics, an eye surgery clinic in London, announced that he has performed KAMRA Vision surgery, the proven solution to reading glasses, on two distinguished ophthalmologists.

21 Nov 2012

Rituximab may help patients with aPL-related clinical problems

Rituximab, a drug used to treat cancer and arthritis, may help patients with antiphospholipid antibodies (aPLs) who suffer from aPL-related clinical problems that do not respond to anticoagulation, such as cardiac disease and kidney disease, according to a new study by rheumatology researchers at Hospital for Special Surgery. The study appears online ahead of print, in the journal Arthritis and Rheumatism.

21 Nov 2012

Sectra OneScreen can effectively identify people at high risk for osteoporosis

A research team at the Karolinska Institute in Stockholm has conducted a study that shows how Sectra's online service, Sectra OneScreen, provides an efficient and inexpensive method for early identification of people in the "at-risk group" for osteoporosis. Sectra OneScreen can be combined with routine mammography examinations.

21 Nov 2012

Discovery of DKK1-WNT pathway reveals new drug targets for Alzheimer's

The discovery of the molecular pathway that drives the changes seen in the brains of Alzheimer's patients is reported today, revealing new targets for drug discovery that could be exploited to combat the disease. The study gives the most detailed understanding yet of the complex processes leading to Alzheimer's.

21 Nov 2012

New polymer nanoparticles can generate heat and kill colorectal cancer cells

Researchers at Wake Forest Baptist Medical Center have modified electrically-conductive polymers, commonly used in solar energy applications, to develop revolutionary polymer nanoparticles (PNs) for a medical application. When the nanoparticles are exposed to infrared light, they generate heat that can be used to kill colorectal cancer cells.

21 Nov 2012

BRIGHTs bind to biomarkers of disease and light up to reveal their location

Called BRIGHTs, the tiny probes described in the online issue of Advanced Materials on Nov. 15, bind to biomarkers of disease and, when swept by an infrared laser, light up to reveal their location.

21 Nov 2012

Sweat glands play a key role in providing cells for skin wound recovery

Turns out the same glands that make you sweat are responsible for another job vital to your health: they help heal wounds. Human skin is rich with millions of eccrine sweat glands that help your body cool down after a trip to the gym or on a warm day. These same glands, new University of Michigan Health System research shows, also happen to play a key role in providing cells for recovering skin wounds - such as scrapes, burns and ulcers.

21 Nov 2012

Scientists uncover new role for TLR4 in development of tissue fibrosis or scarring

An international multi-disciplinary research team led by Northwestern Medicine scientists has uncovered a new role for the protein toll-like receptor 4 (TLR4) in the development of tissue fibrosis, or scarring.

21 Nov 2012

Gabrielle's Angel Foundation announces recipients of new collaborative grants for cancer research

Gabrielle's Angel Foundation for Cancer Research today announced grant recipients of its first-ever Collaborative Research grant program. The inaugural awards total $800,000 for two groundbreaking research initiatives that span the medical capitals of New York, Boston and Chicago.

21 Nov 2012

Simple, accurate testing protocol to determine driving fitness in individuals with MS

A simple, accurate testing protocol to determine driving fitness in individuals with multiple sclerosis is the aim of a three-year study at Georgia Health Sciences University.

21 Nov 2012

Viewpoints: Papa John's complaint; Renewed criticism of Justice Roberts; Calif. voters rout food police

If ObamaCare negatively impacts your business, you better not complain about it. That's what Papa John's CEO John Schnatter found out when he announced the health-care law would increase the price of a pizza by up to 14 cents. ... But Papa John's isn't the only restaurant chain to complain that the Affordable Care Act is bad for business.

21 Nov 2012

Health professionals may soon have new method to diagnose Parkinson's

Health professionals may soon have a new method of diagnosing Parkinson's disease, one that is noninvasive and inexpensive, and, in early testing, has proved to be effective more than 90 percent of the time.

21 Nov 2012

Medical Condition News

Study demonstrates memory-enhancing effects of low-level light therapy

FDA accepts MAP Pharmaceuticals’ resubmission of NDA for LEVADEX

UPR pathway helps tumor cells escape apoptosis during development of lymphoma

No differences between computer-navigated and traditional TKA related to knee function, pain

Rexahn's quinoxalinyl-piperazine compounds receive U.S. patent

Regorafenib able to control resistant gastrointestinal stromal tumor

Australian TGA approves Genzyme’s AUBAGIO to treat relapsing forms of multiple sclerosis

Viewpoints: Protecting us from counterfeit medicines; Governors making excuses on insurance exchanges?; Simpson-Bowles and the health law

FOCUS Clinics Director performs KAMRA Vision surgery on two distinguished ophthalmologists

Rituximab may help patients with aPL-related clinical problems

Sectra OneScreen can effectively identify people at high risk for osteoporosis

Discovery of DKK1-WNT pathway reveals new drug targets for Alzheimer's

New polymer nanoparticles can generate heat and kill colorectal cancer cells

BRIGHTs bind to biomarkers of disease and light up to reveal their location

Sweat glands play a key role in providing cells for skin wound recovery

Scientists uncover new role for TLR4 in development of tissue fibrosis or scarring

Gabrielle's Angel Foundation announces recipients of new collaborative grants for cancer research

Simple, accurate testing protocol to determine driving fitness in individuals with MS

Viewpoints: Papa John's complaint; Renewed criticism of Justice Roberts; Calif. voters rout food police

Health professionals may soon have new method to diagnose Parkinson's

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Latest News